Tripeptide amides that block viral infectivity and methods of use thereof
AssigneeTripep AB
InventorsDavid van der Spoel, Csaba Hetényi, Ákos Végvári, Stefan Höglund, Jin Su, Sarah Sandin-Reneby, Laura Goobar-Larsson, Anders Vahlne
Life of this patent
Estimating the term…
Abstract
Embodiments relate to the discovery that tripeptide amides, which correspond to viral capsid sequences, can be used to inhibit viral infection, including human immunodeficiency virus (HIV) infection. More specifically, medicaments comprising tripeptide amides and methods of using said compounds for the prevention and treatment of viral infection, such as HIV infection, are provided.
Claims5
A composition comprising PRO-LYS-GLU-NH2.
A pharmaceutical composition comprising PRO-LYS-GLU-NH2.
A tripeptide amide consisting of PRO-LYS-GLU-NH2.
Dependencies are inferred from the claim text.